CAPPED BONUSZERTIFIKAT - STRYKER CORP. Stock

Certificat

DE000PC5RTZ8

Market Closed - Boerse Frankfurt Warrants 03:40:11 2024-05-10 pm EDT
320 EUR +0.52% Intraday chart for CAPPED BONUSZERTIFIKAT - STRYKER CORP.
Current month-0.11%
1 month+0.09%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
24-05-10 319 +0.23% 0
24-05-09 318.3 +0.16% 0
24-05-08 317.8 -0.29% 0
24-05-07 318.7 +1.04% 0
24-05-06 315.5 -0.25% 0

Real-time Boerse Frankfurt Warrants

Last update May 10, 2024 at 03:40 pm EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5RTZ
ISINDE000PC5RTZ8
Date issued 2024-02-27
Strike 360 $
Maturity 2024-09-20 (133 Days)
Parity 1 : 1
Emission price 310.9
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 321.4
Lowest since issue 310.7
Spread 0.5
Spread %0.16%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW